Identification of a novel signature in progression of non-small cell lung cancer based on HdWGCNA and in vitro validation

Abstract Background Lung cancer is the predominant contributor to cancer-induced mortality, with non-small cell lung cancer (NSCLC) constituting the majority. However, the intricacies of tumorigenesis and progression in this context remain incompletely understood. Methods Utilizing single-cell RNA s...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Kunpeng Zhang, Wenqiang Xia, Yi Li, Bowen Shi, Weiwei Yang
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2026-02-01
Serija:	BMC Medical Genomics
Teme:	HdWGCNA Immune microenvironment Immunotherapy Non-small cell lung cancer Prognostic signature
Online dostop:	https://doi.org/10.1186/s12920-026-02328-3
Oznake:	Označite Brez oznak, prvi označite!